Olio Labs
Combination therapeutics for the world's toughest diseases
Founded 2023 · $8.7M raised
- Employees
- 1–10
- Founded
- 2023
- Website
- oliolabs.co
- Total Funding
- $8.7M
- Last Round
- $4.5M Series AMar 2025
- Rounds
- 2
About
Olio labs uses AI to develop combination therapeutics that consider the thousands of interacting proteins in your body rather than targeting just one or two. Their lead combinations target obesity and are more effective with fewer side effects than Ozempic, the fastest growing drug of all time. Their custom ML built from real-world expertise and cutting edge AI searches trillions of combinations to find the perfect one.
Summary
Olio Labs is a Healthcare company, founded in 2023. It has raised $8.7M in total across 2 rounds, most recently a $4.5M Series A round in Mar 2025. Investors include Y Combinator, Boom Capital and Overwater Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Mar 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe